Abstract
Background: Hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) gene mutation have been postulated as a possible cause of recurrent miscarriage (RM). There is a wide variation in the prevalence of MTHFR polymorphisms and homocysteine (Hcy) plasma levels among populations around the world. The present study was undertaken to investigate the possible association between hyperhomocysteinemia and its causative genetic or acquired factors and RM in Catalonia, a Mediterranean region in Spain.
Methods: Sixty consecutive patients with ≥3 unexplained RM and 30 healthy control women having at least one child but no previous miscarriage were included. Plasma Hcy levels, MTHFR gene mutation, red blood cell (RBC) folate and vitamin B12 serum levels were measured in all subjects.
Results: No significant differences were observed neither in plasma Hcy levels, RBC folate and vitamin B12 serum levels nor in the prevalence of homozygous and heterozygous MTHFR gene mutation between the two groups studied.
Conclusions: In the present study RM is not associated with hyperhomocysteinemia, and/or the MTHFR gene mutation.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Ardawi MS, Rouzi AA, Qari MH. Influence of age, sex, folate and vitamin B12 status on plasma homocysteine in Saudis. Saudi Med J 2002;23:959–68.Search in Google Scholar
2. Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC. Homocysteine and risk of coronary artery disease: folate is the important determinant of plasma homocysteine concentration. Nutrition 2003;19:577–83.10.1016/S0899-9007(02)01098-5Search in Google Scholar
3. Lim HS, Heo YR. Plasma total homocysteine, folate and vitamin B12 status in Korean adults. J Nutr Sci Vitaminol 2002;48:290–7.10.3177/jnsv.48.290Search in Google Scholar PubMed
4. Sassi S, Cosmi B, Palareti G, Legnani C, Grossi G, Musolesi S, et al. Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica 2002;87:957–64.Search in Google Scholar
5. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10- methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142–50.Search in Google Scholar
6. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7–9.10.1161/01.CIR.93.1.7Search in Google Scholar
7. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005;132:171–96.10.1111/j.1365-2141.2005.05847.xSearch in Google Scholar PubMed
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111–3.10.1038/ng0595-111Search in Google Scholar PubMed
9. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 2006;24:54–66.10.1055/s-2006-931801Search in Google Scholar PubMed
10. Altomare I, Adler A, Aledort LM. The 5,10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature. Thromb J 2007;5: 17–20.10.1186/1477-9560-5-17Search in Google Scholar PubMed PubMed Central
11. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833–43.10.1093/clinchem/44.8.1833Search in Google Scholar
12. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042–50.10.1056/NEJM199804093381507Search in Google Scholar PubMed
13. Stamler JS, Osborne JA, Jaraki O. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91: 308–18.10.1172/JCI116187Search in Google Scholar PubMed PubMed Central
14. Arcaro G, Fava C, Dagradi R, Faccini G, Gaino S, Degan M, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Hyperten 2004;22:775–81.10.1097/00004872-200404000-00021Search in Google Scholar
15. Pruefer D, Scalia R, Lefer AM. Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen Pharmacol 1999;33:487–98.10.1016/S0306-3623(99)00045-2Search in Google Scholar
16. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991;88:1906–14.10.1172/JCI115514Search in Google Scholar
17. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 1996;126:285–9.10.1093/jn/126.suppl_4.1285SSearch in Google Scholar
18. Dhajuria A, Houston DS. Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood 2000;96:966–72.10.1182/blood.V96.3.966Search in Google Scholar
19. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod 2000;15:954–60.10.1093/humrep/15.4.954Search in Google Scholar
20. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris JC. A women with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998;69:152–4.10.1016/S0015-0282(97)00451-2Search in Google Scholar
21. Quere I, Mercier E, Bellet H, Janbon C, Marès P, Gris JC. Vitamin supplementation and pregnancy outcome in women with early recurrent pregnancy loss and hyperhomocysteinemia. Fertil Steril 2001;75:823–5.10.1016/S0015-0282(01)01678-8Search in Google Scholar
22. Gueant JL, Candito M, Andres E, Van Obberghen E, Nicolas JP. Familial pernicious anaemia with hyperhomocysteinemia in recurrent early pregnancy loss. Thromb Haemost 2004;92:1147–9.10.1055/s-0037-1614292Search in Google Scholar
23. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 1998;136:347–54.10.1016/S0021-9150(97)00237-2Search in Google Scholar
24. Guéant-Rodriguez RM, Guéant-Rodriguez JL, Debard R, Thirion S, Xiao Hong L, Bronowicki JP, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006;83:701–7.10.1093/ajcn.83.3.701Search in Google Scholar
25. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the Third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:482–9.10.1093/ajcn/69.3.482Search in Google Scholar
26. Ubbink JB, Vermaak WJ, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 1995;62:802–8.10.1093/ajcn/62.4.802Search in Google Scholar
27. Nair RR, Khanna A, Singh K. MTHFR C677T polymorphism and recurrent early pregnancy loss risk in north Indian population. Reprod Sci 2012;19:210–5.10.1177/1933719111417888Search in Google Scholar
28. Wu X, Zhao L, Zhu H, He D, Tang W, Luo Y. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: a meta-analysis. Genet Test Mol Biomarkers 2012;16:806–11.10.1089/gtmb.2011.0318Search in Google Scholar
29. Holmes ZR, Regan K, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol 1999;105:98–101.10.1111/j.1365-2141.1999.01319.xSearch in Google Scholar
30. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999;181:120–30.10.1016/S0002-9378(99)70447-3Search in Google Scholar
31. Hübner U, Alwan A, Jouma M, Tabbaa M, Schorr H, Herrmann W. Low serum vitamin B12 is associated with recurrent pregnancy loss in Syrian women. Clin Chem Lab Med 2008;46:1265–9.10.1515/CCLM.2008.247Search in Google Scholar PubMed
32. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3–32.10.1373/clinchem.2003.021634Search in Google Scholar PubMed
33. De Bree A, Verschuren WM, Blom HJ, Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001;154:150–4.10.1093/aje/154.2.150Search in Google Scholar PubMed
34. Herrmann W, Schorr H, Purschwitz K, Rassoul F, Richter V. Total homocysteine, vitamin B12 and total antioxidant status in vegetarians. Clin Chem 2001;47:1094–101.10.1093/clinchem/47.6.1094Search in Google Scholar
35. Tewari PC, Zhang B, Bluestein BL. Analytical and clinical evaluation of the Bayer ADVIA Centaur homocysteine assay. Clin Chim Acta 2004;342:171–8.10.1016/j.cccn.2003.12.025Search in Google Scholar
36. Demuth K, Ducros V, Michelsohn S, Paul JL. Evaluation of Advia Centaur automated chemiluminescence immunoassay for determining total homocysteine in plasma. Clin Chim Acta 2004;349:113–20.10.1016/j.cccn.2004.06.012Search in Google Scholar
37. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002;8:463–81.10.1093/humupd/8.5.463Search in Google Scholar
38. ACOG Practice Bulletin. Management of recurrent early pregnancy loss. Int J Gynecol Obstet 2002;78:179–90.Search in Google Scholar
39. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125–30.10.1055/s-2003-38897Search in Google Scholar
40. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004;114:409–14.10.1016/j.thromres.2004.08.004Search in Google Scholar
41. Silver RM, Warren JE. Preconception counselling for women with thrombophilia. Clin Obstet Gynecol 2006;49:906–19.10.1097/01.grf.0000211959.53498.a4Search in Google Scholar
42. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820–5.10.1016/S0015-0282(16)56282-7Search in Google Scholar
43. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, et al. Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 2000;11:657–62.10.1097/00001721-200010000-00010Search in Google Scholar
44. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent pregnancy loss. Obstet Gynecol 2000;95:519–24.Search in Google Scholar
45. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997;350:861.10.1016/S0140-6736(97)24038-9Search in Google Scholar
46. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1998;71:1048–53.10.1016/S0015-0282(99)00133-8Search in Google Scholar
47. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010;93:1234–43.10.1016/j.fertnstert.2009.01.166Search in Google Scholar
48. Seremak-Mrozikiewicz A, Drews K, Kurzawinska G, Bogacz A, Grzeskowiak E, Mrozikiewicz PM. The significance of 1793G>A polymorphism in MTHFR gene in women with first trimester recurrent miscarriages. Neuro Endocrinol Lett 2010;31:717–23.Search in Google Scholar
49. Kurzawińska G, Seremak-Mrozikiewicz A, Drews K, Barlik M, Mrozikiewicz PM. Genetic conditioned changes in activity of 5,10-methylenetetrahydrofolate reductase (MTHFR) and recurrent miscarriages. Ginekol Pol 2009;80:762–7.Search in Google Scholar
50. Cardona H, Cardona-Maya W, Gómez JG, Castañeda S, Gómez JM, Bedoya G, et al. Relationship between methylenetetrahydrofolate reductase polymorphism and homocysteine levels in women with recurrent pregnancy loss: a nutrigenetic perspective. Nutr Hosp 2008;23:277–82.Search in Google Scholar
51. Zammiti W, Mtiraoui N, Mahjoub T. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in Tunisian women. Am J Reprod Immunol 2008;59: 139–45.10.1111/j.1600-0897.2007.00551.xSearch in Google Scholar
52. Sikora J, Magnucki J, Zietek J, Kobielska L, Partyka R, Kokocinska D, et al. Homocysteine serum concentration and uterine artery color Doppler examination in cases of recurrent miscarriages with unexplained etiology. Neuro Endocrinol Lett 2007;28:502–6.Search in Google Scholar
53. Muñoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folate intake during pregnancy. Lancet 1998;352:1120–1.10.1016/S0140-6736(05)79761-0Search in Google Scholar
54. Pijoán JI, Irigoien I, Aguirre C. Intervalos de referencia poblacional y determinantes de la homocisteína plasmática. Med Clin 2001;117:487–91.10.1016/S0025-7753(01)72153-7Search in Google Scholar
55. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French supplementation with antioxidant vitamins and minerals study. Am J Clin Nutr 2002;76:1279–89.10.1093/ajcn/76.6.1279Search in Google Scholar PubMed
56. Steegers-Theunissen R, Van Iersel CA, Peer PG, Nelen WL, Steegers EA. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet Gynecol 2004;104: 336–43.10.1097/01.AOG.0000129955.47943.2aSearch in Google Scholar PubMed
57. Obeid R, Herrmann W. Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid. Clin Chem Lab Med 2007;45:1746–50.10.1515/CCLM.2007.361Search in Google Scholar PubMed
58. Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem 2012;56:301–22.10.1007/978-94-007-2199-9_16Search in Google Scholar PubMed
59. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nut 2011;94:313S–21S.10.3945/ajcn.111.013243Search in Google Scholar PubMed PubMed Central
60. Miller JW, Ribaya-Mercado JD, Russell RM, Shepard DC, Morrow FD, Cochary EF, et al. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 1992;55:1154–60.10.1093/ajcn/55.6.1154Search in Google Scholar
61. Wolters M, Hermann S, Hahn A. B vitamin status and concentrations of homocysteine and methylmalonic acid in elderly German women. Am J Clin Nutr 2003;78:765–72.10.1093/ajcn/78.4.765Search in Google Scholar
62. Yetley EA. Monitoring folate status in population-based surveys. Biofactors 2011;37:285–9.10.1002/biof.176Search in Google Scholar
63. Pfeiffer CM, Schleicher RL, Johnson CL, Coates PM. Assessing vitamin status in large population surveys by measuring biomarkers and dietary intake – two case studies: folate and vitamin D. Food Nutr Res 2012;56:5944.10.3402/fnr.v56i0.5944Search in Google Scholar
64. Van Hecke MV, Dekker JM, Nijpels G, Teerlink T, Jakobs C, Stolk RP, et al. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. Clin Sci (Lond) 2008;114: 479–87.10.1042/CS20070275Search in Google Scholar
65. Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007;451:694–9.10.1515/CCLM.2007.341Search in Google Scholar
66. Guillen M, Corella D, Pórtoles O, González JI, Mulet F, Sáiz C. Prevalence of de methylenetetrahydrofolate reductase 677T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors. Eur J Epidemiol 2001;17:255–61.10.1023/A:1017978503416Search in Google Scholar
67. Krabbendam I, Franx A, Bots ML, Fijnheer R, Bruinse HW. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 2005;118:143–53.10.1016/j.ejogrb.2004.07.019Search in Google Scholar
68. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;9361:901–8.10.1016/S0140-6736(03)12771-7Search in Google Scholar
69. Sütterlin M, Bussen S, Ruppert D, Steck T. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod 1997;12:1292–6.10.1093/humrep/12.10.2292Search in Google Scholar PubMed
70. Sikora J, Magnucki J, Zietek J, Kobielska L, Partyka R, Kokocinska D, et al. Homocysteine, folic acid, and vitamin B12 concentration in patients with recurrent miscarriages. Neuroendocrinol Lett 2007;28:507–12.Search in Google Scholar
71. Scott JM, Weir DG, Kirke PN. Folate and neural tube defects. In: Bailey LB, editor. Folate in health and disease. New York, NY: Marcel Dekker, 1995:329–60.Search in Google Scholar
72. Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992;42:32–42.Search in Google Scholar
73. Piertzik K, Prinz R, Reusch K, Bung P, Mallmann P, Chronides A. Folate status and pregnancy outcome. Ann N Y Acad Sci 1992;669:371–3.10.1111/j.1749-6632.1992.tb17127.xSearch in Google Scholar PubMed
74. George L, Mills JL, Johansson AL, Nordmarck A, Olander B, Granath F, et al. Plasma folate levels and risk of spontaneous abortion. J Am Med Assoc 2002;288:1867–73.10.1001/jama.288.15.1867Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
